Steward Partners Investment Advisory, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,215,500
-19.3%
650,000
+8.3%
0.02%
-17.4%
Q2 2023$1,506,000
+36.5%
600,000
-4.8%
0.02%
+27.8%
Q1 2023$1,103,498
-14.9%
630,570
+106.7%
0.02%
-18.2%
Q4 2022$1,296,250
+8541.7%
305,000
+15150.0%
0.02%
Q2 2021$15,000
-99.9%
2,000
-50.0%
0.00%
Q1 2021$23,480,000
+260788.9%
4,000
+100.0%
0.00%
Q4 2020$9,0002,0000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders